{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:04:01Z","timestamp":1784221441849,"version":"3.55.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arcmed.2026.103412","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:42:59Z","timestamp":1774863779000},"page":"103412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unconventional Uses of Human Growth Hormone"],"prefix":"10.1016","volume":"57","author":[{"given":"Marcos","family":"Lisbona-Buzali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3975-6542","authenticated-orcid":false,"given":"Gabriela","family":"Edid-Jaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9361-3585","authenticated-orcid":false,"given":"Alberto","family":"Alegre-Lifshitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4025-7105","authenticated-orcid":false,"given":"Sophia","family":"Mercado-Medrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-7398","authenticated-orcid":false,"given":"Keiko","family":"Taniguchi-Ponciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marrero-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-9734","authenticated-orcid":false,"given":"Moises","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2026.103412_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1584303","article-title":"Secretion of placental peptide hormones: functions and trafficking","volume":"16","author":"Ahmadi","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0002","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1515\/JPEM.2000.13.4.343","article-title":"The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development","volume":"13","author":"Handwerger","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0303-7207(98)00040-9","article-title":"Physiological role of human placental growth hormone","volume":"140","author":"Alsat","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0004","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/br.2017.930","article-title":"Human placental growth hormone in normal and abnormal fetal growth","volume":"7","author":"Velegrakis","year":"2017","journal-title":"Biomed Rep"},{"key":"10.1016\/j.arcmed.2026.103412_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1073\/pnas.8.3.38","article-title":"Characteristic Effects upon Growth, Oestrus and Ovulation Induced by the Intraperitoneal Administration of Fresh Anterior Hypophyseal Substance","volume":"8","author":"Evans","year":"1922","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2026.103412_bib0006","series-title":"The Pituitary (Third Edition) [Internet]","first-page":"83","article-title":"Chapter 4 - Growth Hormone","author":"VS","year":"2011"},{"key":"10.1016\/j.arcmed.2026.103412_bib0007","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ghir.2009.04.011","article-title":"Growth hormone isoforms","volume":"19","author":"Baumann","year":"2009","journal-title":"Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc"},{"key":"10.1016\/j.arcmed.2026.103412_bib0008","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygeno.2011.06.001","article-title":"Gene conversions in the growth hormone gene family of primates: Stronger homogenizing effects in the Hominidae lineage","volume":"98","author":"Petronella","year":"2011","journal-title":"Genomics"},{"key":"10.1016\/j.arcmed.2026.103412_bib0009","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1210\/endrev\/bnae030","article-title":"Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies","volume":"46","author":"Basu","year":"2025","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ceca.2011.12.005","article-title":"Influence of membrane ion channel in pituitary somatotrophs by hypothalamic regulators","volume":"51","author":"Yang","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.arcmed.2026.103412_bib0011","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1210\/jc.2004-1935","article-title":"Increased Density of Ghrelin-Expressing Cells in the Gastric Fundus and Body in Prader-Willi Syndrome","volume":"90","author":"Choe","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0012","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2009-0010","article-title":"The role of liver-derived insulin-like growth factor-I","volume":"30","author":"Ohlsson","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0013","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2005.11.001","article-title":"Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects","volume":"16","author":"Fisker","year":"2006","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0015","first-page":"731","article-title":"Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues","volume":"78","author":"Mercado","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0016","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1210\/me.2014-1153","article-title":"Dynamic analysis of GH receptor conformational changes by split luciferase complementation","volume":"28","author":"Liu","year":"2014","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0017","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ghir.2015.06.001","article-title":"The growth hormone receptor","volume":"28","author":"Waters","year":"2016","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","article-title":"The Growth Hormone Receptor: Mechanism of Receptor Activation","volume":"9","author":"Dehkhoda","year":"2018","journal-title":"Cell Signaling, and Physiological Aspects. Front Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0019","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ghir.2017.12.006","article-title":"GH and GHR signaling in human disease","volume":"38","author":"Guevara-Aguirre","year":"2018","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0020","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/gerona\/glac092","article-title":"Growth Hormone, Not IGF-1 Is the Key Longevity Regulator in Mammals","volume":"77","author":"Brown-Borg","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.arcmed.2026.103412_bib0021","article-title":"Nuclear localization and actions of the insulin-like growth factor 1 (IGF-1) system components: Transcriptional regulation and DNA damage response","volume":"784","author":"Poreba","year":"2020","journal-title":"Mutat Res Mutat Res"},{"issue":"Suppl 3","key":"10.1016\/j.arcmed.2026.103412_bib0022","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.4103\/2230-8210.84852","article-title":"History of growth hormone therapy","volume":"15","author":"Ayyar","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12098-011-0609-4","article-title":"History of growth hormone therapy","volume":"79","author":"Blizzard","year":"2012","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0024","series-title":"Endotext. South","article-title":"Disorders of Growth Hormone in Childhood","author":"Murray","year":"2000"},{"key":"10.1016\/j.arcmed.2026.103412_bib0025","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry","volume":"854","year":"1995","journal-title":"Report of a WHO Expert Committee. World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.arcmed.2026.103412_bib0026","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2006-2017","article-title":"Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society","volume":"92","author":"Clayton","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2026.103412_bib0027","first-page":"129","article-title":"Natural growth in children born SGA with and without catch up growth","volume":"59","author":"Albertsson-Wikland","year":"2003","journal-title":"Horm Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0028","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/endrev\/bnad002","article-title":"International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood","volume":"44","author":"Hokken-Koelega","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0029","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1542\/peds.2009-0293","article-title":"Impact of growth hormone therapy on adult height of children born small for gestational age","volume":"124","author":"Maiorana","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcmed.2026.103412_bib0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1210\/clinem\/dgac694","article-title":"Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age","volume":"108","author":"Juul","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0031","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.5199","article-title":"Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity","volume":"175","author":"Tidblad","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0032","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2265.2004.02171.x","article-title":"Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA)","volume":"62","author":"Arends","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2026.103412_bib0034","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jcem.87.1.8293","article-title":"High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity","volume":"87","author":"de Zegher","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52332-0","article-title":"Childhood growth hormone treatment in women with Turner syndrome - benefits and adverse effects","volume":"9","author":"Irzyniec","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2026.103412_bib0036","doi-asserted-by":"crossref","first-page":"395","DOI":"10.30574\/wjarr.2024.23.1.2023","article-title":"Effects of growth hormone and sex steroid therapy on brain structure and pituitary function in turner syndrome","volume":"23","author":"Soliman","year":"2024","journal-title":"World J Adv Res Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0037","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.yapd.2022.03.005","article-title":"Clinical Indications for Growth Hormone Therapy","volume":"69","author":"Danowitz","year":"2022","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0038","first-page":"1810","article-title":"Spontaneous Pubertal Development in Turner\u2019s Syndrome","volume":"82","author":"Pasquino","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0039","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ghir.2011.09.004","article-title":"The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age","volume":"21","author":"Kappelgaard","year":"2011","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/ijem.IJEM_36_17","article-title":"Growth Hormone Treatment in Turner\u2019s Syndrome: A Real World Experience","volume":"21","author":"Reddy Danda","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0041","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvae050","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome","author":"Gravholt","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0042","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1096-6374(98)80124-X","article-title":"Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult turner syndrome: the impact of body composition, maximal oxygen uptake and treatment with sex hormones","volume":"8","author":"Gravholt","year":"1998","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0043","first-page":"1814","article-title":"Absence of growth hormone effects on cognitive function in girls with Turner syndrome","volume":"82","author":"Ross","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0044","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2147\/TCRM.S70068","article-title":"Growth hormone therapy for Prader-willi syndrome: challenges and solutions","volume":"12","author":"Grugni","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.arcmed.2026.103412_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.23838\/pfm.2023.00079","article-title":"Prader-Willi syndrome and growth hormone therapy: exploring the precise management of hypothalamic short stature: A review","volume":"7","author":"Yang","year":"2023","journal-title":"Precis Future Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0046","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/clinem\/dgab406","article-title":"Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis","volume":"106","author":"Rosenberg","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2020.102084","article-title":"Growth hormone treatment for Prader-Willi syndrome: A review","volume":"83","author":"Yang","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.arcmed.2026.103412_bib0048","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s40618-021-01574-9","article-title":"Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches","volume":"44","author":"Muscogiuri","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.arcmed.2026.103412_bib0049","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1687-9856-2011-12","article-title":"Prader-Willi syndrome: A primer for clinicians","volume":"2011","author":"Cataletto","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jpeds.2004.01.056","article-title":"Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index\u2013a cross-sectional study","volume":"144","author":"Vestergaard","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0051","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eprac.2025.02.004","article-title":"Central Hypothyroidism: Advances in Etiology, Diagnostic Challenges, Therapeutic Targets, and Associated Risks","volume":"31","author":"Iglesias","year":"2025","journal-title":"Endocr Pract"},{"key":"10.1016\/j.arcmed.2026.103412_bib0052","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.pcl.2015.03.004","article-title":"Prader-Willi, Angelman, and 15q11-q13 duplication syndromes","volume":"62","author":"Kalsner","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.arcmed.2026.103412_bib0053","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/ajmg.a.31824","article-title":"Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment","volume":"143A","author":"Angulo","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.arcmed.2026.103412_bib0054","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12020-020-02547-3","article-title":"Effects of growth hormone on cognitive, motor, and behavioral development in Prader-Willi syndrome children: a meta-analysis of randomized controlled trials","volume":"71","author":"Luo","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.arcmed.2026.103412_bib0055","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2265.2007.03126.x","article-title":"Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome","volume":"68","author":"Festen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2026.103412_bib0056","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0057","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcmed.2026.103412_bib0058","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","article-title":"Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease","volume":"15","author":"Drube","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0059","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-007-0527-x","article-title":"Growth hormone axis in chronic kidney disease","volume":"23","author":"Mahesh","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0060","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1681\/ASN.2006111207","article-title":"Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk","volume":"18","author":"Feldt-Rasmussen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0061","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/ajcn\/82.6.1235","article-title":"Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients","volume":"82","author":"Pupim","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0062","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMra1807442","article-title":"Management of Burns","volume":"380","author":"Greenhalgh","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0063","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1186\/s12889-022-13887-2","article-title":"The epidemiological characteristic and trends of burns globally","volume":"22","author":"Yakupu","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.arcmed.2026.103412_bib0064","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF02067111","article-title":"The role of mediators in the response to thermal injury","volume":"16","author":"Youn","year":"1992","journal-title":"World J Surg"},{"issue":"Suppl B","key":"10.1016\/j.arcmed.2026.103412_bib0065","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S1096-6374(00)80008-8","article-title":"Growth hormone, burns and tissue healing","volume":"10","author":"Lal","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0066","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0305-4179(98)00159-4","article-title":"Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury","volume":"25","author":"Demling","year":"1999","journal-title":"Burns J Int Soc Burn Inj"},{"key":"10.1016\/j.arcmed.2026.103412_bib0067","doi-asserted-by":"crossref","unstructured":"Rutan RL, Herndon DN. Growth delay in postburn pediatric patients. Arch Surg Chic Ill 19601990;125:392-395.","DOI":"10.1001\/archsurg.1990.01410150114021"},{"key":"10.1016\/j.arcmed.2026.103412_bib0068","doi-asserted-by":"crossref","unstructured":"Gore DC, Honeycutt D, Jahoor F, et al. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg Chic Ill 19601991;126:38-43.","DOI":"10.1001\/archsurg.1991.01410250042006"},{"key":"10.1016\/j.arcmed.2026.103412_bib0069","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/00000658-199506000-00004","article-title":"Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns","volume":"221","author":"Herndon","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2026.103412_bib0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00000658-199010000-00005","article-title":"Effects of recombinant human growth hormone on donor-site healing in severely burned children","volume":"212","author":"Herndon","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2026.103412_bib0071","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00000658-199810000-00001","article-title":"Growth hormone treatment in pediatric burns: a safe therapeutic approach","volume":"228","author":"Ramirez","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2026.103412_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2015.12.009","article-title":"Effects of sustained release growth hormone treatment during the rehabilitation of adult severe burn survivors","volume":"27","author":"Kim","year":"2016","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0073","article-title":"Recombinant human growth hormone for treating burns and donor sites","volume":"2014","author":"Breederveld","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0074","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV infection","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.arcmed.2026.103412_bib0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.anplas.2024.10.006","article-title":"Current status and perspectives in the treatment of facial lipoatrophy in HIV-positive patients in 2024","volume":"70","author":"Tilhet","year":"2025","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1016\/j.arcmed.2026.103412_bib0076","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.beem.2010.11.001","article-title":"Growth hormone and HIV infection: contribution to disease manifestations and clinical implications","volume":"25","author":"Falutz","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0077","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1210\/jcem.86.8.7785","article-title":"The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation","volume":"86","author":"Lo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0078","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1310\/hct0904-254","article-title":"Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone","volume":"9","author":"Macallan","year":"2008","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.arcmed.2026.103412_bib0079","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1293.2010.00906.x","article-title":"Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials","volume":"12","author":"Sivakumar","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11154-013-9245-9","article-title":"Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV\/AIDS","volume":"14","author":"Jain","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.arcmed.2026.103412_bib0081","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1089\/aid.2023.0048","article-title":"Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort","volume":"39","author":"Wohlfeiler","year":"2023","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.arcmed.2026.103412_bib0082","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.nut.2006.03.011","article-title":"Nutritional and metabolic abnormalities in pre-AIDS HIV infection","volume":"22","author":"Faintuch","year":"2006","journal-title":"Nutrition"},{"issue":"Suppl 2","key":"10.1016\/j.arcmed.2026.103412_bib0083","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/cid\/ciae407","article-title":"Expert Consensus Statement on an Updated Definition of Unintended Weight Loss Among Persons With Human Iwithodeficiency Virus in the Modern Treatment Era","volume":"79","author":"Bedimo","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2026.103412_bib0084","article-title":"Wasting in HIV infection and AIDS","volume":"129","author":"Macallan","year":"1999","journal-title":"J Nutr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0085","article-title":"Clinical Trials for the Treatment of Secondary Wasting and Cachexia","volume":"129","author":"Raiten","year":"1999","journal-title":"J Nutr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0086","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.111.012625","article-title":"Energy expenditure in HIV infection","volume":"94","author":"Kosmiski","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0087","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3080969","article-title":"Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients","volume":"2023","author":"Pan","year":"2023","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0088","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.594820","article-title":"Regulation of Gut Microbiota on Immune Reconstitution in Patients With Acquired Immunodeficiency Syndrome","volume":"11","author":"Geng","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0089","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/500398","article-title":"Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort","volume":"42","author":"Mangili","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcmed.2026.103412_bib0090","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group","volume":"125","author":"Schambelan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0091","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.arcmed.2026.103412_bib0092","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2026.103412_bib0093","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.arcmed.2026.103412_bib0094","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hfc.2018.05.002","article-title":"Growth Hormone Therapy in Heart Failure","volume":"14","author":"Salzano","year":"2018","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.arcmed.2026.103412_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.arcmed.2026.103412_bib0096","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ghir.2005.09.002","article-title":"Growth hormone- and pressure overload-induced cardiac hypertrophy evoke different responses to ischemia-reperfusion and mechanical stretch","volume":"16","author":"Str\u00f6mer","year":"2006","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0097","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1152\/ajplegacy.1969.217.6.1795","article-title":"Effects of growth hormone and insulin on amino acid transport in perfused rat heart","volume":"217","author":"Hjalmarson","year":"1969","journal-title":"Am J Physiol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0098","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jchf.2024.11.017","article-title":"Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"13","author":"Marra","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.arcmed.2026.103412_bib0099","first-page":"989","article-title":"Growth hormone in heart failure revisited: An old story retold","volume":"88","author":"Cittadini","year":"2018","journal-title":"Monaldi Arch Chest Dis Arch Monaldi Mal Torace"},{"key":"10.1016\/j.arcmed.2026.103412_bib0100","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(97)11329-0","article-title":"Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy","volume":"351","author":"Osterziel","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2026.103412_bib0101","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1210\/jc.2007-1189","article-title":"Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure","volume":"92","author":"Fazio","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0167-5273(02)00249-8","article-title":"Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status","volume":"87","author":"Acevedo","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0103","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jc.2006-1313","article-title":"Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis","volume":"92","author":"Le Corvoisier","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0104","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4158\/EP.14.1.40","article-title":"Growth hormone therapy in congestive heart failure due to left ventricular systolic dysfunction: a meta-analysis","volume":"14","author":"Tritos","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.arcmed.2026.103412_bib0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-060972","article-title":"Towards definitions of critical illness and critical care using concept analysis","volume":"12","author":"Kayambankadzanja","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.arcmed.2026.103412_bib0106","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/bja\/aeu187","article-title":"Metabolic response to the stress of critical illness","volume":"113","author":"Preiser","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.arcmed.2026.103412_bib0107","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/CCM.0b013e318265f21c","article-title":"Endocrine, metabolic, and morphologic alterations of adipose tissue during critical illness","volume":"41","author":"Marques","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0108","first-page":"438","article-title":"Is there a role for growth hormone therapy in refractory critical illness?","volume":"14","author":"Taylor","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.arcmed.2026.103412_bib0109","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.beem.2011.06.002","article-title":"The GH\/IGF-1 System in Critical Illness","volume":"25","author":"Elijah","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0002-9610(96)00033-5","article-title":"Use of growth hormone for postoperative respiratory failure","volume":"171","author":"Knox","year":"1996","journal-title":"Am J Surg"},{"key":"10.1016\/j.arcmed.2026.103412_bib0111","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","article-title":"Increased mortality associated with growth hormone treatment in critically ill adults","volume":"341","author":"Takala","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0112","first-page":"1868","article-title":"Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0113","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12887-021-02609-z","article-title":"Racially equitable diagnosis of cystic fibrosis using next-generation DNA sequencing: a case report","volume":"21","author":"Shum","year":"2021","journal-title":"BMC Pediatrics"},{"key":"10.1016\/j.arcmed.2026.103412_bib0114","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-017-1193-9","article-title":"Cystic fibrosis: current therapeutic targets and future approaches","volume":"15","author":"Rafeeq","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion Channel Modulators in Cystic Fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.arcmed.2026.103412_bib0116","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.medcli.2023.06.006","article-title":"Cystic fibrosis: Epidemiology, clinical manifestations, diagnosis and treatment","volume":"161","author":"Diab C\u00e1ceres","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arcmed.2026.103412_bib0117","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042921-021447","article-title":"Cystic Fibrosis Modulator Therapies","volume":"74","author":"Jia","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/pir.2019-0212","article-title":"Cystic Fibrosis","volume":"42","author":"Dickinson","year":"2021","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0119","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jpeds.2015.07.044","article-title":"Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years","volume":"167","author":"Sanders","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-277X.1995.tb00311.x","article-title":"Growth hormone as a nutritional adjunct in cystic fibrosis: results of a pilot study","volume":"8","author":"Sackey","year":"1995","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.arcmed.2026.103412_bib0121","article-title":"Recombinant growth hormone therapy for cystic fibrosis in children and young adults","volume":"2021","author":"Thaker","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0122","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/adc.88.12.1078","article-title":"Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis","volume":"88","author":"Schibler","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcmed.2026.103412_bib0123","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ppul.21546","article-title":"A Multi-Center Controlled Trial of Growth Hormone Treatment in Children with Cystic Fibrosis","volume":"47","author":"Stalvey","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0124","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1067\/mpd.2001.119452","article-title":"Growth hormone and cystic fibrosis: Good for more than growth?","volume":"139","author":"Bucuvalas","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00007256-200434020-00002","article-title":"Growth hormone and exercise tolerance in patients with cystic fibrosis","volume":"34","author":"H\u00fctler","year":"2004","journal-title":"Sports Med Auckl NZ"},{"key":"10.1016\/j.arcmed.2026.103412_bib0126","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1542\/peds.2010-2007","article-title":"Recombinant human growth hormone in the treatment of patients with cystic fibrosis","volume":"126","author":"Phung","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcmed.2026.103412_bib0127","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpeds.2004.10.037","article-title":"Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition","volume":"146","author":"Hardin","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcmed.2026.103412_bib0128","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2006-1101","article-title":"Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial","volume":"91","author":"Hardin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0129","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ecl.2012.07.001","article-title":"Growth and growth hormone treatment in children with chronic diseases","volume":"41","author":"Pozzo","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.arcmed.2026.103412_bib0130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1183\/09031936.00103907","article-title":"Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients","volume":"31","author":"Grasemann","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arcmed.2026.103412_bib0131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1941738118782688","article-title":"The Use and Abuse of Human Growth Hormone in Sports","volume":"10","author":"Siebert","year":"2018","journal-title":"Sports Health"},{"key":"10.1016\/j.arcmed.2026.103412_bib0132","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2011-1035","article-title":"Growth Hormone Doping in Sports: A Critical Review of Use and Detection Strategies","volume":"33","author":"Baumann","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0133","doi-asserted-by":"crossref","first-page":"576","DOI":"10.20945\/2359-3997000000187","article-title":"The promise of growth hormone in sport: doped or duped","volume":"63","author":"Ho","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0134","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/er.2018-00265","article-title":"The Use and Abuse of Growth Hormone in Sports","volume":"40","author":"Holt","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ghir.2017.05.005","article-title":"Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials","volume":"34","author":"Hermansen","year":"2017","journal-title":"Growth Horm IGF Res"},{"issue":"Suppl 2","key":"10.1016\/j.arcmed.2026.103412_bib0136","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.33549\/physiolres.934523","article-title":"Aging, Hormones and Receptors","volume":"69","author":"Hill","year":"2020","journal-title":"Physiol Res"},{"key":"10.1016\/j.arcmed.2026.103412_bib0137","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0749-0690(18)30143-5","article-title":"The somatopause: should growth hormone deficiency in older people Be treated?","volume":"13","author":"Lieberman","year":"1997","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199007053230101","article-title":"Effects of human growth hormone in men over 60 years old","volume":"323","author":"Rudman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0139","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5603\/FM.a2023.0005","article-title":"The association between body height and longevity: evidence from a national population sample","volume":"83","author":"Chmielewski","year":"2024","journal-title":"Folia Morphol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0140","article-title":"Shorter men live longer: association of height with longevity and FOXO3 genotype in American men of Japanese ancestry","volume":"9","author":"He","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2026.103412_bib0141","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/acel.12213","article-title":"Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity","volume":"13","author":"Milman","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.arcmed.2026.103412_bib0142","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s11357-022-00623-2","article-title":"Age-related decline in circulating IGF-1 associates with impaired neurovascular coupling responses in older adults","volume":"44","author":"Toth","year":"2022","journal-title":"Geroscience"},{"key":"10.1016\/j.arcmed.2026.103412_bib0143","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11357-019-00065-3","article-title":"Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice","volume":"41","author":"Farias-Quipildor","year":"2019","journal-title":"Geroscience"},{"key":"10.1016\/j.arcmed.2026.103412_bib0144","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103412_bib0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fendo.2013.00064","article-title":"Adult Growth Hormone Deficiency - Benefits, Side Effects, and Risks of Growth Hormone Replacement","volume":"4","author":"Reed","year":"2013","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0146","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41574-021-00539-5","article-title":"Advances in differential diagnosis and management of growth hormone deficiency in children","volume":"17","author":"Hage","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0147","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MED.0b013e32834ec952","article-title":"Diagnosis of growth hormone deficiency in childhood","volume":"19","author":"Stanley","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.arcmed.2026.103412_bib0148","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/er.2018-00216","article-title":"Growth Hormone Deficiency: Health and Longevity","volume":"40","author":"Aguiar-Oliveira","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2026.103412_bib0149","unstructured":"US. Food and Drug Administration. Import Alert 66-71. Available from: https:\/\/www.accessdata.fda.gov\/cms_ia\/importalert_204.html. (Accessed June 6, 2025)."},{"key":"10.1016\/j.arcmed.2026.103412_bib0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0004-27302011000800009","article-title":"Adverse effects of growth hormone replacement therapy in children","volume":"55","author":"Souza","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.arcmed.2026.103412_bib0151","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-146-2-200701160-00005","article-title":"Systematic review: the safety and efficacy of growth hormone in the healthy elderly","volume":"146","author":"Liu","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arcmed.2026.103412_bib0152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2024.101584","article-title":"Growth hormone treatment in aged patients with comorbidities: A systematic review","volume":"75","author":"Tausendfreund","year":"2024","journal-title":"Growth Horm IGF Res"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440926000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440926000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:11:58Z","timestamp":1784218318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440926000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":152,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0188440926000354"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103412","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unconventional Uses of Human Growth Hormone","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Instituto Mexicano del Seguro Social (IMSS).","name":"copyright","label":"Copyright"}],"article-number":"103412"}}